臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 2817768
	???header.visitor??? : 27875921 ???header.onlineuser??? : 446 ???header.sponsordeclaration???

???search.scope???

???search.advance???

???search.login???

???search.administrator???

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"saraf s"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-11 of 11 (1 Page(s) Totally)
1
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-08-19T00:20:40Z	Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: Results of the KEYnote-028 study	Hansen A.R.; Cheng J.D.; Thanigaimani P.; Saraf S.; CHIUN HSU; Lee S.-H.; Ejadi S.; Even C.; Cohen R.B.; Le Tourneau C.; Mehnert J.M.; Algazi A.; Van Brummelen E.M.J.
臺大學術典藏	2021-04-23T05:56:26Z	Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC	Awad M.M.;Gadgeel S.M.;Borghaei H.;Patnaik A.;Chih-Hsin Yang;Powell S.F.;Gentzler R.D.;Martins R.G.;Stevenson J.P.;Altan M.;Jalal S.I.;Panwalkar A.;Gubens M.;Sequist L.V.;Saraf S.;Zhao B.;Piperdi B.;Langer C.J.; Awad M.M.; Gadgeel S.M.; Borghaei H.; Patnaik A.; CHIH-HSIN YANG; Powell S.F.; Gentzler R.D.; Martins R.G.; Stevenson J.P.; Altan M.; Jalal S.I.; Panwalkar A.; Gubens M.; Sequist L.V.; Saraf S.; Zhao B.; Piperdi B.; Langer C.J.
臺大學術典藏	2021-03-09T06:46:02Z	Pembrolizumab for the treatment of advanced salivary gland carcinoma	Cohen R.B.;Delord J.-P.;Doi T.;Piha-Paul S.A.;Liu S.V.;Gilbert J.;Algazi A.P.;Damian S.;Ruey-Long Hong;Le Tourneau C.;Day D.;Varga A.;Elez E.;Wallmark J.;Saraf S.;Thanigaimani P.;Cheng J.;Keam B.; Cohen R.B.; Delord J.-P.; Doi T.; Piha-Paul S.A.; Liu S.V.; Gilbert J.; Algazi A.P.; Damian S.; RUEY-LONG HONG; Le Tourneau C.; Day D.; Varga A.; Elez E.; Wallmark J.; Saraf S.; Thanigaimani P.; Cheng J.; Keam B.
臺大學術典藏	2020-12-28T06:25:46Z	Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid?Aortic?Valve Stenosis	Bleiziffer S.; Yoon S.-H.; Deuschl F.; Saraf S.; Holy E.W.; Khalique O.K.; Perlman G.Y.; Sharma R.; Barbanti M.; Ziegelmueller J.; De Backer O.; Delgado V.; Arai T.; Abramowitz Y.; Maeno Y.; Kawamori H.; Sugiyama D.; Tay E.; Kong W.K.F.; Schofer N.; Ohno Y.; Schmidt T.; Kaneko H.; Takahashi M.; Pache G.; Fujita B.; Ruile P.; Neumann F.-J.; Leipsic J.; Blanke P.; Dvir D.; Schaefer U.; Ensminger S.M.; Butter C.; Teiger E.; Testa L.; Bedgoni F.; Chakravarty T.; Nakamura M.; Kuwata S.; Yong G.; HSIEN-LI KAO; Lee M.; Kim H.-S.; Modine T.; Wong S.C.; Park S.-J.; Whisenant B.K.; Hildick-Smith D.; Tamburino C.; Nietlispach F.; Abdel-Wahab M.; Chevalier B.; Makkar R.; Leon M.B.; Lefèvre T.; Webb J.G.; Søndergaard L; Bax J.J.; Colombo A.; Latib A.; Kodali S.K.
臺大學術典藏	2020-12-25T08:38:36Z	Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis	Kawamori H.; Tay E.; Sugiyama D.; Kong W.K.F.; Yoon S.-H.; Bleiziffer S.; De Backer O.; Delgado V.; Arai T.; Ziegelmueller J.; Barbanti M.; Sharma R.; Perlman G.Y.; Khalique O.K.; Holy E.W.; Saraf S.; Deuschl F.; Fujita B.; Ruile P.; Neumann F.-J.; Pache G.; Takahashi M.; Kaneko H.; Schmidt T.; Ohno Y.; Schofer N.; Maeno Y.; Abramowitz Y.; Chakravarty T.; Nakamura M.; Kuwata S.; Yong G.; HSIEN-LI KAO; Lee M.; Kim H.-S.; Modine T.; Wong S.C.; Bedgoni F.; Testa L.; Teiger E.; Butter C.; Ensminger S.M.; Schaefer U.; Dvir D.; Blanke P.; Leipsic J.; Nietlispach F.; Abdel-Wahab M.; Chevalier B.; Tamburino C.; Hildick-Smith D.; Whisenant B.K.; Park S.-J.; Colombo A.; Latib A.; Kodali S.K.; Bax J.J.; Søndergaard L.; Webb J.G.; Lefèvre T.; Leon M.B.; Makkar R.
臺大學術典藏	2020-05-26T09:26:25Z	Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non?�small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study	Papadimitrakopoulou V.;Raftopoulos H;Saraf S;Bachman R;Sequist L.V;Chih-Hsin Yang;Hauke R;Gubens M;Villaruz L.C;Patnaik A;Borghaei H;Gandhi L;Langer C.J;Stevenson J.P;Gadgeel S.M; Gadgeel S.M; Stevenson J.P; Langer C.J; Gandhi L; Borghaei H; Patnaik A; Villaruz L.C; Gubens M; Hauke R; CHIH-HSIN YANG; Sequist L.V; Bachman R; Saraf S; Raftopoulos H; Papadimitrakopoulou V.
臺大學術典藏	2020-05-26T09:26:24Z	24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non?�Small Cell Lung Cancer	Borghaei H;Langer C.J;Gadgeel S;Papadimitrakopoulou V.A;Patnaik A;Powell S.F;Gentzler R.D;Martins R.G;Stevenson J.P;Jalal S.I;Panwalkar A;Chih-Hsin Yang;Gubens M;Sequist L.V;Awad M.M;Fiore J;Saraf S;Keller S.M;Gandhi L.; Borghaei H; Langer C.J; Gadgeel S; Papadimitrakopoulou V.A; Patnaik A; Powell S.F; Gentzler R.D; Martins R.G; Stevenson J.P; Jalal S.I; Panwalkar A; CHIH-HSIN YANG; Gubens M; Sequist L.V; Awad M.M; Fiore J; Saraf S; Keller S.M; Gandhi L.
臺大學術典藏	2020-05-26T09:26:22Z	Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation	Raftopoulos H; Patnaik A.; Saraf S; Fiore J; Su W.-C; Papadimitrakopoulou V.A; Wu C.-L; Sequist L.V; Gadgeel S.M; CHIH-HSIN YANG; Chih-Hsin Yang;Gadgeel S.M;Sequist L.V;Wu C.-L;Papadimitrakopoulou V.A;Su W.-C;Fiore J;Saraf S;Raftopoulos H;Patnaik A.
臺大學術典藏	2020-05-25T07:35:07Z	Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer	Saraf S; Thanigaimani P; Cheng J.D; Keam B.; Mehnert J.M; Varga A; Brose M.S; Aggarwal R.R; Chia-Chi Lin; Prawira A; De Braud F; Tamura K; Doi T; Piha-Paul S.A; Gilbert J
臺大學術典藏	2020-04-10T12:51:01Z	Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: Results of the KEYNOTE-028 study	Chiun Hsu;Lee S.-H.;Ejadi S.;Even C.;Cohen R.B.;Le Tourneau C.;Mehnert J.M.;Algazi A.;Van Brummelen E.M.J.;Saraf S.;Thanigaimani P.;Cheng J.D.;Hansen A.R.; Chiun Hsu; Lee S.-H.; Ejadi S.; Even C.; Cohen R.B.; Le Tourneau C.; Mehnert J.M.; Algazi A.; Van Brummelen E.M.J.; Saraf S.; Thanigaimani P.; Cheng J.D.; Hansen A.R.
臺大學術典藏	2020-03-02T06:40:17Z	Automatic design of machining fixtures: Conceptual design	Chou, Y.-C.; Srinivas, R.A.; Saraf, S.; YON-CHUN CHOU

Showing items 1-11 of 11 (1 Page(s) Totally)
1
View [10|25|50] records per page